He, Yongzheng
c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions. [electronic resource]
- PloS one 2012
- e46900 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1932-6203
10.1371/journal.pone.0046900 doi
Animals
Bone Resorption--drug therapy
Cell Adhesion--drug effects
Cell Movement--drug effects
Cells, Cultured
Enzyme Inhibitors--therapeutic use
Extracellular Signal-Regulated MAP Kinases--metabolism
Female
Gene Deletion
Humans
Macrophage Colony-Stimulating Factor--metabolism
Mice
Mice, Inbred C57BL
Neurofibromin 1--genetics
Osteoclasts--cytology
Osteoporosis--drug therapy
Receptor, Macrophage Colony-Stimulating Factor--antagonists & inhibitors
Ribosomal Protein S6 Kinases, 90-kDa--metabolism
Signal Transduction